Company profile

Lusofarmaco is well known to the medical community for its commitment and dedication to scientific information activity, with a “mission” to provide strong support to the activities of health promotion and therapeutic management of commonly occurring diseases. 
Lusofarmaco has an extensive know-how in a number of therapeutic areas: from cardiovascular diseases to respiratory diseases, from antibiotic therapy to neuropsychiatric and gynaecology.
 

The cardiovascular area include drugs for the management of arterial hypertension, ischaemic heart disease, myocardial infarction, heart failure, and hypercholesterolaemia. The respiratory area has been enriched by two active substances with proven efficacy for the treatment of obstructive respiratory diseases. Lusofarmaco is historically present in the neuropsychiatric field, and can rely on a highly effective drug in the treatment of migraine, an important antipsychotic drug, and an effective antidepressant drug.

In the section of antibiotic therapy there are drugs used to treat upper and lower respiratory tract infections and genito-urinary tract infections.

As a proof of its commitment in the scientific information field, Lusofarmaco has requested and obtained the prestigious SGS certificate, issued by the world's leading certification company, which demonstrates that the products, processes, systems, and services of the Company meet national and international standards and regulations.
 


Click here to visualize the certificate 

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.